Electrical optimization of cardiac resynchronization in chronic heart failure is associated with improved clinical long-term outcome

被引:13
作者
Adlbrecht, Christopher [1 ]
Huelsmann, Martin [1 ]
Gwechenberger, Marianne [1 ]
Graf, Senta [1 ]
Wiesbauer, Franz [1 ]
Strunk, Guido [3 ]
Khazen, Cesar [2 ]
Brodnjak, Isabella [1 ]
Neuhold, Stephanie [1 ]
Binder, Thomas [1 ]
Maurer, Gerald [1 ]
Pacher, Richard [1 ]
机构
[1] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Cardiothorac Surg, A-1090 Vienna, Austria
[3] Vienna Univ Econ & Business, Res Inst Hlth Care Management & Econ, Vienna, Austria
关键词
AV-delay; AV-time; cardiac resynchronization therapy; electrical optimization; heart failure; outcome; CARE-HF TRIAL; DELAY OPTIMIZATION; CARDIOVERTER-DEFIBRILLATOR; THERAPY; MORTALITY; DYSSYNCHRONY; DESIGN; CRT; IMPLANTATION; PREDICTORS;
D O I
10.1111/j.1365-2362.2010.02311.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Background Cardiac resynchronization therapy (CRT) is an established treatment option for symptomatic chronic heart failure (CHF) patients with pharmacological baseline therapy, but not all patients benefit from device therapy. One reason for this may be inadequate device settings. In real-world practice, echocardiographic evaluation of atrioventricular (AV) delay is not performed in a high proportion of patients, as the effect of electrical optimization of CRT is an issue open for investigation. Materials and methods We performed a retrospective observational study analysing the effect of AV-interval evaluation with echocardiography on long-term [32 (23?43) months] clinical outcome in 205 CHF patients. A stepwise Cox regression model including a co-morbidity score, failed AV-interval evaluation, satisfactory device function after the first implantation attempt, failure to reach 100% of the recommended renin-angiotensin system inhibitor and beta-blocker dose at follow-up and CRT device implantation compared with CRT in combination with an implanted cardioverter defibrillator (ICD) was applied. Results In the total study cohort, 124 (60 center dot 5%) patients had reached the primary combined endpoint death or cardiac hospitalization and 59 (28 center dot 8%) had died. Cox regression analysis revealed that failed AV-interval evaluation [HR = 1 center dot 72 (1 center dot 19-2 center dot 49), P = 0 center dot 004] non-optimized CHF pharmacotherapy dosages [HR = 2 center dot 12 (1 center dot 32-3 center dot 42), P = 0 center dot 002], the presence of a CRT/ICD combination device [HR = 1 center dot 87 (1 center dot 28-2 center dot 71), P = 0 center dot 001] and satisfactory device function after the first implantation attempt [HR = 0 center dot 44 (0 center dot 25-0 center dot 77), P = 0 center dot 004] were associated with the primary endpoint. Conclusion Echocardiographic evaluation of the AV-interval in patients with CRT was independently associated with improved clinical outcome, impacting on daily clinical practice of HF patient care.
引用
收藏
页码:678 / 684
页数:7
相关论文
共 26 条
  • [1] Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment
    Adlbrecht, C.
    Huelsmann, M.
    Gwechenberger, M.
    Strunk, G.
    Khazen, C.
    Wiesbauer, F.
    Elhenicky, M.
    Neuhold, S.
    Binder, T.
    Maurer, G.
    Lang, I. M.
    Pacher, R.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (12) : 1073 - 1081
  • [2] Auricchio A, 2002, J AM COLL CARDIOL, V39, p124A
  • [3] Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Bardy, GH
    Lee, KL
    Mark, DB
    Poole, JE
    Packer, DL
    Boineau, R
    Domanski, M
    Troutman, C
    Anderson, J
    Johnson, G
    McNulty, SE
    Clapp-Channing, N
    Davidson-Ray, LD
    Fraulo, ES
    Fishbein, DP
    Luceri, RM
    Ip, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) : 225 - 237
  • [4] Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization
    Barold, S. Serge
    Ilercil, Arzu
    Herweg, Bengt
    [J]. EUROPACE, 2008, 10 : 88 - 95
  • [5] Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study
    Berger, Rudolf
    Shankar, Aparna
    Fruhwald, Friedrich
    Fahrleitner-Pammer, Astrid
    Freemantle, Nick
    Tavazzi, Luigi
    Cleland, John G. F.
    Pacher, Richard
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 (17) : 2109 - 2116
  • [6] Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization
    Boriani, Giuseppe
    Diemberger, Igor
    Biffi, Mauro
    Martignani, Cristian
    Valzania, Cinzia
    Ziacchi, Matteo
    Bertini, Matteo
    Specchia, Salvatore
    Grigioni, Francesco
    Rapezzi, Claudio
    Branzi, Angelo
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2006, 17 (03) : 215 - 224
  • [7] A Prospective Randomized Evaluation of VV Delay Optimization in CRT-D Recipients: Echocardiographic Observations from the RHYTHM II ICD Study
    Boriani, Giuseppe
    Biffi, Mauro
    Mueller, Cord Paul
    Seidl, Karl-Heinz
    Grove, Rainer
    Vogt, Juergen
    Danschel, Wilfried
    Schuchert, Andreas
    Deharo, Jean-Claude
    Becker, Thorsten
    Boulogne, Eric
    Trappe, Hans Joachim
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 : S120 - S125
  • [8] Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    Bristow, MR
    Saxon, LA
    Boehmer, J
    Krueger, S
    Kass, DA
    De Marco, T
    Carson, P
    DiCarlo, L
    DeMets, D
    White, BG
    DeVries, DW
    Feldman, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2140 - 2150
  • [9] The effect of cardiac resynchronization on morbidity and mortality in heart failure
    Cleland, JGF
    Daubert, J
    Erdmann, E
    Freemantle, N
    Gras, D
    Kappenberger, L
    Tavazzi, L
    Cleland, JGF
    Daubert, JC
    Erdmann, E
    Gras, D
    Kappenberger, L
    Klein, W
    Tavazzi, L
    Poole-Wilson, PA
    Rydén, L
    Wedel, H
    Wellens, HJJ
    Uretsky, B
    Thygesen, K
    Böcker, D
    Marijianowski, MMH
    Freemantle, N
    Calvert, MJ
    Christ, G
    Fruhwald, F
    Hofmann, R
    Krypta, A
    Leisch, F
    Pacher, R
    Rauscha, F
    Tavernier, R
    Thomsen, PEB
    Boesgaard, S
    Eiskjær, H
    Esperen, GT
    Haarbo, J
    Hagemann, A
    Korup, E
    Moller, M
    Mortensen, P
    Sogaard, P
    Vesterlund, T
    Huikuri, H
    Niemelä, KI
    Toivonen, L
    Bauer, F
    Cohen-Solal, A
    Crocq, C
    Djiane, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) : 1539 - 1549
  • [10] The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points
    Cleland, JGF
    Daubert, JC
    Erdmann, E
    Freemantle, N
    Gras, D
    Kappenberger, L
    Klein, W
    Tavazzi, L
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (04) : 481 - 489